Healthcare >> Analyst Interviews >> September 18, 2014
Molecular Diagnostic Companies Aim to Capitalize on Decentralized Testing
Nicholas Jansen joined Raymond James & Associates, Inc., in June 2006 as part of the health care research team focusing primarily on the services space, becoming an Analyst in 2011. During his time at the firm, his coverage broadened to encompass the pharma distribution channel, and his primary coverage responsibility now includes clinical laboratories, the human and veterinary diagnostics field, and health care information technology. Mr. Jansen has been recognized in the StarMine survey for estimate accuracy. He graduated from the University of Florida with a M.S. in finance, with undergraduate degrees in finance and economics as well. Profile
TWST: Can you start a short overview of your coverage, including some of the names you follow?
Mr. Jansen: Yes, my primary coverage responsibility is within the clinical lab and the